First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis

Abstract Purpose Epithelioid hemangioendothelioma (EHE) represents an ultra-rare, translocated vascular sarcoma with a heterogeneous course of disease. The optimal systemic treatment for patients with advanced EHE remains unclear. We sought to evaluate the value of pazopanib (PAZ) as a first-line tr...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Anton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, Markus Albertsmeier, Michael Hoberger, Hans Roland Dürr, Alexander Klein, Thomas Knösel, Wolfgang G. Kunz, Andreas Mock, Ada Pusztai, Michael Völkl, Michael von Bergwelt-Baildon, Lars H. Lindner, Dorit Di Gioia, Luc M. Berclaz
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2025-04-01
Serija:	Journal of Cancer Research and Clinical Oncology
Teme:	Epithelioid hemangioendothelioma Rare cancers Metastasis Pazopanib Targeted therapy
Online dostop:	https://doi.org/10.1007/s00432-025-06208-8
Oznake:	Označite Brez oznak, prvi označite!